{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-011857","form_type":"8-K","ticker":"SILO","cik":"0001514183","company_name":"Silo Pharma, Inc.","filed_at":"2022-03-11T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.812581+00:00","generated_at":"2026-06-26T23:34:50.708574+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Silo Pharma shareholders approve reverse stock split of 1-for-5 to 1-for-50","bullets":["Shareholders granted Board discretion to effect a reverse split at a ratio between 1:5 and 1:50.","Reverse split must be completed by February 8, 2023.","Vote totals: 53,847,792 in favor, 11,915 against, 240 abstain.","Quorum of 53,859,947 shares represented at the special meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-011857","json":"https://secwatch.observer/filing/0001213900-22-011857.json","markdown":"https://secwatch.observer/filing/0001213900-22-011857.md","text":"https://secwatch.observer/filing/0001213900-22-011857.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1514183/000121390022011857/0001213900-22-011857-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1514183/000121390022011857/ea156769-8k_silopharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T23:34:50.708574+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}